With our rich industry experience in this domain, we are engaged in offering Z-Cita-200 mg which is perfect to treat cancers of the pancreas, lung, ovary, and breast. The offered range is utilized alone or with other treatments/medications to treat certain types of cancer. Our offered Z-Cita-200 mg is in high demand due to its high quality and accurate composition. Further, our range is basically a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
Others, Cash Against Delivery (CAD)
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
"We are inviting inquiries only from South America, Africa, Middle East, Cih, South East Asia."
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD.
1302, Rupa Solitaire, Millenium Business Park (MBP), Next to Hotel Ramada, Mahape, Navi Mumbai - 400710, Maharashtra, India